For research use only. Not for therapeutic Use.
Utreloxastatum(CAT: I037900) is a potent and selective inhibitor targeting key enzymes involved in metabolic and inflammatory pathways. It is widely used in research exploring conditions such as metabolic disorders, chronic inflammation, and immune-related diseases. By modulating specific enzymatic activity, Utreloxastatum helps unravel molecular mechanisms and supports the discovery of therapeutic interventions. Its high purity and stability ensure consistent and accurate experimental results. Ideal for biochemical and pharmacological studies, Utreloxastatum is a valuable tool for advancing research in enzyme regulation and its implications in health and disease.
| Catalog Number | I037900 |
| CAS Number | 1213269-96-5 |
| Synonyms | utreloxastatum; utreloxastat |
| Molecular Formula | C18H28O2 |
| Purity | 98% |
| Target | α-synuclein |
| Appearance | Solid powder |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| IUPAC Name | 2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione |
| InChI | InChI=1S/C18H28O2/c1-5-6-7-8-9-10-11-12-16-15(4)17(19)13(2)14(3)18(16)20/h5-12H2,1-4H3 |
| InChIKey | IJWAQTHZBDBIID-UHFFFAOYSA-N |
| SMILES | O=C1C(C)=C(C)C(C(C)=C1CCCCCCCCC)=O |
